Neuphoria Therapeutics (NEUP) Non-Current Deferred Tax Liability (2023 - 2026)
Neuphoria Therapeutics (NEUP) posted Non-Current Deferred Tax Liability of $355,940 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 28.1% from $495,113 a year earlier and down 8.9% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Non-Current Deferred Tax Liability (2023 - 2026) Analysis & Trends
Since fiscal Q4 2023, Neuphoria Therapeutics has reported Non-Current Deferred Tax Liability for 10 quarters.
- Annual Non-Current Deferred Tax Liability has declined for three consecutive fiscal years, with a three-year compound annual growth rate of -31.4% (FY2023 to FY2026).
- In prior fiscal years, Neuphoria Therapeutics' Non-Current Deferred Tax Liability was $495,113 in FY2025 (-48.6%), $963,540 in FY2024 (-12.6%) and $1.1 million in FY2023.
- The fiscal Q4 2026 figure stands as the lowest quarterly Non-Current Deferred Tax Liability in data going back to fiscal Q4 2023.
- On a year-over-year basis, Non-Current Deferred Tax Liability has declined in each of the last five quarters, with an average decline of 43.9% over the last five quarters.
- According to Business Quant data, Non-Current Deferred Tax Liability for the three prior fiscal quarters was $390,733 (Q3 2026), $425,527 (Q2 2026) and $460,320 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.98 Bn | 1,134.57 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 643.66 Bn | 563.53 Bn | 17.30 Bn |
| 3 | AbbVie | 500.95 Bn | 474.06 Bn | 12.70 Bn |
| 4 | Merck | 358.08 Bn | 312.45 Bn | 12.21 Bn |
| 5 | Novartis Ag | 301.84 Bn | 265.83 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.25 Bn | 240.94 Bn | 12.86 Bn |
| 7 | Amgen | 241.42 Bn | 196.81 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn |
| 10 | Neuphoria Therapeutics | 436.98 Mn | 361.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 355,940.00 |
| Mar 31, 2026 | 390,733.00 |
| Dec 31, 2025 | 425,527.00 |
| Sep 30, 2025 | 460,320.00 |
| Jun 30, 2025 | 495,113.00 |
| Mar 31, 2025 | 761,737.00 |
| Dec 31, 2024 | 842,921.00 |
| Sep 30, 2024 | 831,324.00 |
| Jun 30, 2024 | 963,540.00 |
| Jun 30, 2023 | 1.10 Mn |
API Access
Neuphoria Therapeutics Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();